Abstract

For men with favorable-risk prostate cancer, active surveillance — a strategy of prospectively assessing changes in disease biology, stage, and grade to determine the need for curative intervention — has increasingly become an alternative consideration to immediate therapy in selected patients with low-risk prostate cancer. Now, to provide more robust data on outcomes associated with active surveillance, investigators report updated results of a prospective, single-center, single-arm, cohort study of this …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call